期刊论文详细信息
Italian Journal of Pediatrics
Bone health in children with long–term idiopathic subclinical hypothyroidism
Mariacarolina Salerno2  Claudio Pignata2  Francesca Santamaria2  Ciro Mainolfi1  Donatella Capalbo2  Andrea Esposito2  Nicola Improda2  Manuela Cerbone2  Raffaella Di Mase2 
[1] Department of Radiology, University of Naples, Federico II, Naples, Italy;Department of Pediatrics, University of Naples, Federico II, Naples, Italy
关键词: Subclinical hypothyroidism;    QUS;    DXA;    Bone Mineral density;    Bone;   
Others  :  825645
DOI  :  10.1186/1824-7288-38-56
 received in 2012-09-14, accepted in 2012-10-18,  发布年份 2012
PDF
【 摘 要 】

Background

Subclinical hypothyroidism (SH) is a relatively common condition characterized by a mild persistent thyroid failure. The management of children with SH is still a controversial issue and the decision to treat with L-thyroxine represents a clinical dilemma. Thyroid hormone and TSH play an important role in skeletal growth and bone mineral homeostasis.

Aim

To evaluate whether untreated idiopathic SH may affect bone health in childhood and to compare two different diagnostic tools such as dual-energy X-ray densitometry (DXA) and quantitative ultrasound (QUS).

Patients and Methods

Twenty-five children and adolescents (11 males) aged 9.8 ± 3.5 years (range 4.2-18.7) with untreated idiopathic SH were enrolled in the study. SH was diagnosed on the basis of normal FT4 levels with TSH concentrations between 4.2 and 10 mU/l. Children have been followed for 3.3 ± 0.3 years from the time of SH diagnosis. Twenty-five healthy children, age- and sex-matched, were enrolled as controls. Patients and controls underwent DXA to evaluate lumbar spine bone mineral density (BMD) and QUS at proximal phalanges of the non-dominant hand to assess bone quality, measured as amplitude-dependent speed of sound (Ad-SoS) and bone transmission time (BTT).

Results

Mean BMD Z-score was −0.4 ± 1.36 in patients and −0.2 ± 1.2 in controls. Mean Ad-SoS Z-score was 0.01 ± 1.0 in patients and 0.1 ± 1.2 in controls and mean BTT Z-score was −0.03 ± 0.8 and 0.04 ± 1.1 respectively. All values were within the normal range, both in patients and in controls. There were no statistically significant differences between the two groups.

Conclusion

Bone health, evaluated by lumbar spine DXA and phalangeal QUS, is not impaired in our children, despite long-term duration of idiopathic SH. Data about bone status provided by QUS are comparable to those provided by DXA. Therefore, QUS may represent a good, cheaper and safe screening test for bone evaluation in children with SH.

【 授权许可】

   
2012 Di Mase et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20140713071551117.pdf 252KB PDF download
Figure 1. 16KB Image download
【 图 表 】

Figure 1.

【 参考文献 】
  • [1]Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, Franklyn JA, Hershman JM, Burman KD, Denke MA, Gorman C, Cooper RS, Weissman NJ: Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004, 291:228-238.
  • [2]Biondi B: Natural history, diagnosis and management of subclinical thyroid disfunction. Best Pract Res Clin Endocrinol Metab 2012, 26:431-6.
  • [3]Wu T, Flowers JW, Tudiver F, Wilson JL, Punyasavatsut N: Subclinical thyroid disorders and cognitive performance among adolescents in the United State. BMC Pediatr 2006, 6:12. BioMed Central Full Text
  • [4]Villar HC, Saconato H, Valente O, Atallah AN: Thyroid hormone replacement for subclinical hypothyroidism. Cochrane Database Syst Rev 2007, 3:CD003419.
  • [5]Wasniewska M, Salerno M, Cassio A, Corrias A, Aversa T, Zirilli G, Capalbo D, Bal M, Mussa A, De Luca F: Prospective evaluation of the natural course of idiopathic subclinical hypothyroidism in childhood and adolescence. Eur J Endocrinol 2009, 160(3):417-21.
  • [6]Radetti G, Maselli M, Buzi F, Corrias A, Mussa A, Cambiaso P, Salerno M, Cappa M, Baiocchi M, Gastaldi R, Minerba L, Loche S: The natural history of the normal/mild elevated TSH serum levels in children and adolescents with Hashimoto's thyroiditis and isolated hyperthyrotropinaemia: a 3-year follow-up. Clin Endocrinol (Oxf) 2012, 76(3):394-8.
  • [7]Cerbone M, Bravaccio C, Capalbo D, Polizzi M, Wasniewska M, Cioffi D, Improda N, Valenzise M, Bruzzese D, De Luca F, Salerno M: Linear growth and intellectual outcome in children with long-term idiopathic subclinical hypothyroidism. Eur J Endocrinol 2011, 164(4):591-7.
  • [8]Wasniewska M, Corrias A, Aversa T, Valenzise M, Mussa A, De Martino L, Lombardo F, De Luca F, Salerno M: Comparative evaluation of therapy with L-thyroxine versus No treatment in children with idiopathic and mild subclinical hypothyroidism. Horm Res Paediatr 2012, 77(6):376-81.
  • [9]Gogakos AI, Duncan Bassett JH, Williams GR: Thyroid and bone. Arch Biochem Biophys 2010, 503:129-136.
  • [10]Toft AD: Clinical practice. Subclinical hyperthyroidism. N Engl J Med 2001, 345:512-516.
  • [11]Ben-Sholmo A, Hagag P, Evans S, Weiss M: Early postmenopausal bone loss in hyperthyroidism. Maturitas 2001, 39:19-27.
  • [12]Meier C, Nguyen TV, Center JR, Seibel MJ, Eisman JA: Bone resumption and osteoporotic fractures in elderly men: the dubbo osteoporosis epidemiology study. J Bone Miner Res 2005, 20:579-87.
  • [13]Morris MS: The association between serum thyroid-stimulating hormone in its reference range and bone status in postmenopausal American women. Bone 2007, 40:1128-34.
  • [14]Murphy E, Gluer CC, Reid DM, Felsenberg D, Roux C, Eastell R, Williams GR: Thyroid function within the upper normal range is associated with reduced bone mineral density and an increased risk of nonvertebral fractures in healty euthyroid postmenopausal women. J Clin Endocrinol Metab 2010, 95:3173-81.
  • [15]Mazziotti G, Porcelli T, Patelli I, Vescovi PP, Giustina A: Serum THS values and risk of vertebral fractures in euthyroid post-menopausal women with low bone mineral density. Bone 2010, 46:747-51.
  • [16]Kim BJ, Lee SH, Base SJ, Kim HK, Choe JW, Koh JM, Kim GS: The association between serum thyrotropin (TSH) levels and bone mineral density in healthy euthyroid men. Clind Endocrinol (Oxf) 2010, 73:396-403.
  • [17]Eriksen EF, Moskelide L, Melsen F: Kinetics of trabecular bone resorption and formation in hypothyroidism: evidence for a positive balance per remodeling cycle. Bone 1986, 7:101-8.
  • [18]Bertoli A, Fusco A, Andreoli A, Magnani A, Tulli A, Lauro D, De Lorenzo A: Effect of subclinical hypothyroidism and obesity on whole-body and regional bone mineral content. Horm Res 2002, 57:79-84.
  • [19]van der Deure WM, Uitterlinden AG, Hofman A, Rivadeneira F, Pols HA, Peeters RP, Visser TJ: Effects of serum TSH and FT4 levels and the TSHR-Asp727Glu polymorphism on bone: the Rotterdam study. Clin Endocrinol (Oxf) 2008, 68:175-81.
  • [20]Grimnes G, Emaus N, Joakimsen RM, Figenschau Y, Jorde R: The relationship between serum TSH and bone mineral density in men and postmenopausal women: the tromsø study. Thyroid 2008, 18:1147-55.
  • [21]Vestergaard P, Mosekilde L: Fractures in patients with hyperthyroidism and hypothyroidism: a nationwide follow-up study in 16,249 patients. Thyroid 2002, 12:411-9.
  • [22]Vestergaard P, Rejnmark L, Mosekilde L: Influence of hyper- and hypothyroidism, and the effects of treatment with antithyroid drugs and levothyroxine on fracture risk. Calcif Tissue Int 2005, 77:139-44.
  • [23]Abe E, Marians RC, Yu W, Wu XB, Ando T, Li Y, Iqbal J, Eldeiry L, Rajendren G, Blair HC, Davies TF, Zaidi M: TSH is a negative regulator of skeletal remodeling. Cell 2003, 115:151-162.
  • [24]De Sanctis L, Romagnolo D, Olivero M, Buzi F, Maghnie M, Scirè G, Crino A, Baroncelli GI, Salerno M, Di Maio S, Cappa M, Grosso S, Rigon F, Lala R, De Sanctis C, Dianzani I: Molecular analysis of the GNAS1 gene for the correct diagnosis of Albright hereditary osteodystrophy and pseudohypoparathyroidism. Pediatr Res 2003, 53:749-55.
  • [25]Theintz G, Buchs B, Rizzoli R, Slosman D, Clavien H, Sizonenko PC, Bonjour JP: Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years at the levels of lumbar spine and femoral neck in female subjects. J Clin Endocrinol Metab 1992, 75:1060-5.
  • [26]Tanner JM, Whitehouse RH, Takaishi M: Standards from birth to maturity for height, weight, height velocity and weight velocity: British children, 1965. I. Arch Dis Child 1996, 41:454-71.
  • [27]Cacciari E, Milani S, Balsamo A: Directive councils of SIEDP/ISPED for 1996–97 and 2002–03. Italian cross-sectional growth charts for height weight and BMI (2 to 20 yr). J Endocrinol Invest 2006, 29:581-593.
  • [28]Baroncelli GI, Federico G, Vignolo M, Valerio G, Del Punete A, Maghnie M, Baserga M, Farello G, Saggese G: Cross-sectional reference data for phalangeal quantitative ultrasound from early childhood to young-adulthood according to gender, age, skeletal growth, and pubertal development. Bone 2006, 39:159-73.
  • [29]Gordon CM, Baim S, Bianchi ML, Bishop NJ, Hans DB, Kalkwarf H, Langman C, Leonard MB, Plotkin H, Rauch F, Zemel BS, International Society for Clinical Densitometry: Special report on the 2007 pediatric position development conference of the international society for clinical densitometry. South Med J 2008, 101:740-743.
  • [30]Cromer B, Harel Z: Adolescents: at increased risk for osteoporosis? Clin Pediatr (Phila) 2000, 39:565-74.
  • [31]Salerno M, Militerni R, Bravaccio C, Micillo M, Capalbo D, Di Maio S, Tenore A: Effect of different starting doses of levothyroxine on growth and intellectual outcome at four years of age in congenital hypothyroidism. Thyroid 2002, 12:45-52.
  • [32]Salerno M, Lettiero T, Esposito-del Puente A, Esposito V, Capalbo D, Carpinelli A, Padula S, del Puente A: Effect of long-term L-thyroxine treatment on bone mineral density in young adults with congenital hypothyroidism. Eur J Endocrinol 2004, 151:689-694.
  • [33]Demartini Ade A, Kulak CA, Borba VC, Cat MN, Dondoni RS, Sandrini R, Nesi-França S, Lacerda Filho L: Bone mineral density of children and adolescents with congenital hypothyroidism. Arq Bras Endocrinol Metabol 2007, 51:1084-1092.
  • [34]Svare A, Nilsen TI, Bioro T, Forsmo S, Schei B, Langhammer A: Hyperthyroid levels of TSH correlate with low bone mineral density: the HUNT 2 study. Eur J Endocrinol 2009, 161:779-86.
  • [35]Lee WY, Oh KW, Rhee EJ, Jung CH, Kim SW, Yun EJ, Tae HJ, Baek KH, Kang MI, Choi MG, Yoo HJ, Park SW: Relationship between subclinical thyroid dysfunction and femoral neck bone mineral density in women. Arch Med Res 2006, 37:511-6.
  • [36]Lee JS, Buzková P, Fink HA, Vu J, Carbone L, Chen Z, Cauley J, Bauer DC, Cappola AR, Robbins J: Subclinical thyroid dysfunction and incident hip fracture in older adults. Arch Intern Med 2010, 170:1876-83.
  • [37]Nagata M, Suzuki A, Sekiguchi S, Ono Y, Nishiwaki-Yasuda K, Itoi T, Yamamoto S, Imamura S, Katoh T, Hayakawa N, Oda N, Hashimoto S, Itoh M: Subclinical hypothyroidism is related to lower heel QUS in postmenopausal women. Endocr J 2007, 54:625-30.
  文献评价指标  
  下载次数:14次 浏览次数:19次